Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Bullboard Posts
Comment by tuesdaynightridon Jan 19, 2015 8:55pm
152 Views
Post# 23337473

RE:New Board

RE:New BoardI had no intentions of posting until later this year because only 1 in 50 posts had any value due to continuous pumping. That changed once I saw that Bunge has opened up another board and taken all the company spokesmen with him. This is excellent news and should allow for a more honest discussion of TLT's distorted NRs and deceptive timelines. To reiterate my prognosis, TLT will issue about 25-30 million shares shortly after the release of the TLC-2000 by HC. TLT needs the TLC-2000s release to goose the sp as they cannot issue 25 million new shares until sp is well north of $0.50... more like $0.65 Expect share issuance within 1 month of TLC-2000 release. Good bye for now! Should be a more honest, focused board.
Bullboard Posts